Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

Debut trading of AbCellera Biologics, Inc.

12.12.2020

In their debut trading on Friday, December 11 AbCellera Biologics, Inc. (ABCL) showed a 194.50 % and closed at $58.90 per share. Shortly before the company had placed its shares in an IPO priced $20 per share.